EHT899 Uses, Dosage, Side Effects and more

EHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It also apparently enhances a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load.

Trade Name EHT899
Generic EHT899
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Uses

Investigated for use/treatment in hepatitis (viral, B).

How EHT899 works

Studies indicate that EHT899 may induce a secondary immune response against the virus, at the same time reducing the undesirable response associated with HBV infection. Oral intake of viral protein could, in some formulations, induce immunological suppression in chronic carriers.

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share